International Niemann–Pick Disease Alliance
Sometimes in such a big organisation as the INPDA, our various member groups can be overshadowed, but we want...
Read story– Topline results from Phase 1/2 study on track for March 2021 – Individual and cumulative data seen to-date...
Read story– Seasoned biotechnology executive with 20-year successful track record of drug development for rare genetic diseases and extensive worldwide...
Read story